ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Faculty Opinions recommendation of Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1120004.586903
◽
2008
◽
Author(s):
Daniel Vorobiof
◽
Keo Tabane
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase Iii
◽
Advanced Stage
◽
Small Cell Lung
◽
Phase Iii Study
Download Full-text
Related Documents
Cited By
References
Faculty Opinions recommendation of Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.1120004.576128
◽
2008
◽
Author(s):
Nico van Zandwijk
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase Iii
◽
Advanced Stage
◽
Small Cell Lung
◽
Phase Iii Study
Download Full-text
Cisplatin (CDDP) and irinotecan (CPT-11) versus CDDP and vindesine (VDS) in advanced (stage IIIB and stage IV) non-small cell lung cancer (NSCLC). A multicenter phase III study
European Journal of Cancer
◽
10.1016/s0959-8049(99)81409-9
◽
1999
◽
Vol 35
◽
pp. S249-S250
◽
Cited By ~ 3
Author(s):
H. Kunitoh
◽
N. Saijo
◽
K. Nagao
◽
Y. Ohashi
◽
H. Niitani
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Stage Iv
◽
Small Cell
◽
Phase Iii
◽
Advanced Stage
◽
Small Cell Lung
◽
Multicenter Phase
◽
Phase Iii Study
Download Full-text
Phase III Study Comparing Oral Topotecan to Intravenous Docetaxel in Patients With Pretreated Advanced Non–Small-Cell Lung Cancer
Yearbook of Oncology
◽
10.1016/s1040-1741(08)70422-6
◽
2007
◽
Vol 2007
◽
pp. 206-207
Author(s):
N.H. Hanna
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase Iii
◽
Small Cell Lung
◽
Phase Iii Study
◽
Oral Topotecan
Download Full-text
Phase III study of vinflunine versus docetaxel in patients (pts) with advanced non-small cell lung cancer (NSCLC) previously treated with a platinum-containig regimen
Pneumologie
◽
10.1055/s-2008-1074239
◽
2008
◽
Vol 62
(S 2)
◽
Author(s):
J von Pawel
◽
M Reck
◽
R Ramlau
◽
J Jassem
◽
P Zatloukal
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase Iii
◽
Small Cell Lung
◽
Phase Iii Study
◽
Previously Treated
Download Full-text
Faculty Opinions recommendation of Randomized phase III study of surgery alone or surgery plus preoperative cisplatin and gemcitabine in stages IB to IIIA non-small-cell lung cancer.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.13649956.15438060
◽
2012
◽
Author(s):
Paul Van Schil
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase Iii
◽
Small Cell Lung
◽
Phase Iii Study
Download Full-text
Reply to the article “Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study”, by Groen et al. (Ann Oncol 2004; 15: 427–432)
Annals of Oncology
◽
10.1093/annonc/mdh323
◽
2004
◽
Vol 15
(8)
◽
pp. 1298-1299
Author(s):
B. Jeremic
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase Iii
◽
Small Cell Lung
◽
Multicenter Phase
◽
Phase Iii Study
Download Full-text
Phase III study in stage IV non-small-cell lung cancer patients treated with two courses of cisplatin/gemcitabine followed by a randomization to three additional courses of the same combination or gemcitabine alone
Annals of Oncology
◽
10.1093/annonc/mdm061
◽
2007
◽
Vol 18
(5)
◽
pp. 903-908
◽
Cited By ~ 14
Author(s):
S. Novello
◽
P. Bruzzi
◽
C. Barone
◽
R. Buosi
◽
A. Masotti
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cancer Patients
◽
Cell Lung Cancer
◽
Stage Iv
◽
Small Cell
◽
Phase Iii
◽
Small Cell Lung
◽
Lung Cancer Patients
◽
Phase Iii Study
Download Full-text
C3-03: Randomized, phase III Study of mitomycin/vindesine/cisplatin (MVP) versus weekly irinotecan/carboplatin (IC) or weekly paclitaxel/carboplatin (PC) with concurrent thoracic radiotherapy (TRT) for unresectable stage III non-small-cell lung cancer (NSCLC): WJTOG0105
Journal of Thoracic Oncology
◽
10.1097/01.jto.0000283204.17566.c5
◽
2007
◽
Vol 2
(8)
◽
pp. S365-S366
◽
Cited By ~ 1
Author(s):
Kimihide Yoshida
◽
Hisao Uejima
◽
Miyako Satouchi
◽
Shinzoh Kudoh
◽
Kazuhiko Nakagawa
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase Iii
◽
Stage Iii
◽
Thoracic Radiotherapy
◽
Small Cell Lung
◽
Unresectable Stage
◽
Phase Iii Study
Download Full-text
MA07.03 Alectinib (ALC) versus Crizotinib (CRZ) in ALK-Positive Non-Small Cell Lung Cancer (ALK+ NSCLC): Primary Results from Phase III Study (J-ALEX)
Journal of Thoracic Oncology
◽
10.1016/j.jtho.2016.11.427
◽
2017
◽
Vol 12
(1)
◽
pp. S378-S379
◽
Cited By ~ 4
Author(s):
Young Kim
◽
Toyoaki Hida
◽
Hiroshi Nokihara
◽
Masashi Kondo
◽
Koichi Azuma
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase Iii
◽
Small Cell Lung
◽
Phase Iii Study
◽
Alk Positive
Download Full-text
138PD_PR Patient-reported outcomes (PROs) in ALEX: A phase III study of alectinib (ALEC) vs crizotinib (CRIZ) in non-small-cell lung cancer (NSCLC)
Journal of Thoracic Oncology
◽
10.1016/s1556-0864(18)30412-x
◽
2018
◽
Vol 13
(4)
◽
pp. S80-S81
◽
Cited By ~ 1
Author(s):
M. Perol
◽
S. Peters
◽
N. Pavlakis
◽
E. Levchenko
◽
M. Platania
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Patient Reported Outcomes
◽
Small Cell
◽
Phase Iii
◽
Small Cell Lung
◽
Patient Reported
◽
Phase Iii Study
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close